Gonçalves McB, Khera T, Otu H H, Narayanan S, Dillon S T, Shanker A, Gu X, Jung Y, Ngo L H, Marcantonio E R, Libermann T A, Subramaniam B
medRxiv. 2023 Oct 13:2023.05.30.23289741. doi: 10.1101/2023.05.30.23289741.
Delirium following cardiac surgery is common, morbid, and costly, but may be prevented with risk stratification and targeted intervention. Preoperative protein signatures may identify patients at increased risk for worse postoperative outcomes, including delirium. In this study, we aimed to identify plasma protein biomarkers and develop a predictive model for postoperative delirium in older patients undergoing cardiac surgery, while also uncovering possible pathophysiological mechanisms.
SOMAscan analysis of 1,305 proteins in the plasma from 57 older adults undergoing cardiac surgery requiring cardiopulmonary bypass was conducted to define delirium-specific protein signatures at baseline (PREOP) and postoperative day 2 (POD2). Selected proteins were validated in 115 patients using the ELLA multiplex immunoassay platform. Proteins were combined with clinical and demographic variables to build multivariable models that estimate the risk of postoperative delirium and bring light to the underlying pathophysiology.
A total of 115 and 85 proteins from SOMAscan analyses were found altered in delirious patients at PREOP and POD2, respectively (p<0.05). Using four criteria including associations with surgery, delirium, and biological plausibility, 12 biomarker candidates (Tukey's fold change (|tFC|)>1.4, Benjamini-Hochberg (BH)-p<0.01) were selected for ELLA multiplex validation. Eight proteins were significantly altered at PREOP, and seven proteins at POD2 (p<0.05), in patients who developed postoperative delirium compared to non-delirious patients. Statistical analyses of model fit resulted in the selection of a combination of age, sex, and three proteins (angiopoietin-2 (ANGPT2); C-C motif chemokine 5 (CCL5); and metalloproteinase inhibitor 1 (TIMP1); AUC=0.829) as the best performing predictive model for delirium at PREOP. The delirium-associated proteins identified as biomarker candidates are involved with inflammation, glial dysfunction, vascularization, and hemostasis, highlighting the multifactorial pathophysiology of delirium.
Our study proposes a model of postoperative delirium that includes a combination of older age, female sex, and altered levels of three proteins. Our results support the identification of patients at higher risk of developing postoperative delirium after cardiac surgery and provide insights on the underlying pathophysiology. ClinicalTrials.gov ( NCT02546765 ).
心脏手术后出现谵妄很常见,病情严重且成本高昂,但通过风险分层和针对性干预可能预防。术前蛋白质特征可能识别出术后预后较差风险增加的患者,包括谵妄患者。在本研究中,我们旨在识别血浆蛋白质生物标志物,并为接受心脏手术的老年患者建立术后谵妄的预测模型,同时揭示可能的病理生理机制。
对57例接受需要体外循环的心脏手术的老年成年人血浆中的1305种蛋白质进行SOMAscan分析,以确定基线(术前)和术后第2天(POD2)的谵妄特异性蛋白质特征。使用ELLA多重免疫分析平台在115例患者中对选定的蛋白质进行验证。将蛋白质与临床和人口统计学变量相结合,建立多变量模型,以估计术后谵妄的风险并揭示潜在的病理生理学。
在术前和POD2时,分别发现SOMAscan分析中的115种和85种蛋白质在谵妄患者中发生改变(p<0.05)。使用包括与手术、谵妄和生物学合理性相关的四个标准,选择了12种生物标志物候选物(Tukey倍数变化(|tFC|)>1.4,Benjamini-Hochberg(BH)-p<0.01)进行ELLA多重验证。与未发生谵妄的患者相比,术后发生谵妄的患者中有8种蛋白质在术前显著改变,7种蛋白质在POD2时显著改变(p<0.05)。模型拟合的统计分析结果选择年龄、性别和三种蛋白质(血管生成素-2(ANGPT2);C-C基序趋化因子5(CCL5);和金属蛋白酶抑制剂1(TIMP1);AUC=0.829)的组合作为术前谵妄的最佳预测模型。被确定为生物标志物候选物的与谵妄相关的蛋白质涉及炎症、神经胶质功能障碍、血管生成和止血,突出了谵妄的多因素病理生理学。
我们的研究提出了一种术后谵妄模型,该模型包括年龄较大、女性性别和三种蛋白质水平改变的组合。我们的结果支持识别心脏手术后发生术后谵妄风险较高的患者,并提供对潜在病理生理学的见解。ClinicalTrials.gov(NCT02546765)。